美国药品NDC（国家药品编码）与药品说明书数据库（U.S. FDA National Drug Code DataBase）

NDC包装代码	产品NDC	产品类型	商品名	通用名	剂型	给药途径	上市日期	结束日期	市场类别	申请号	标签持有者	活性成分	规格	包装描述
43598-939-01	43598-939	HUMAN PRESCRIPTION DRUG	Topiramate	Topiramate	CAPSULE, EXTENDED RELEASE	ORAL	20260201	N/A	ANDA	ANDA217231	Dr. Reddy’s Laboratories Inc.	TOPIRAMATE	25 mg/1	100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (43598-939-01)
43598-939-30	43598-939	HUMAN PRESCRIPTION DRUG	Topiramate	Topiramate	CAPSULE, EXTENDED RELEASE	ORAL	20260201	N/A	ANDA	ANDA217231	Dr. Reddy’s Laboratories Inc.	TOPIRAMATE	25 mg/1	30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (43598-939-30)
43598-940-01	43598-940	HUMAN PRESCRIPTION DRUG	Topiramate	Topiramate	CAPSULE, EXTENDED RELEASE	ORAL	20260201	N/A	ANDA	ANDA217231	Dr. Reddy’s Laboratories Inc.	TOPIRAMATE	50 mg/1	100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (43598-940-01)
43598-940-30	43598-940	HUMAN PRESCRIPTION DRUG	Topiramate	Topiramate	CAPSULE, EXTENDED RELEASE	ORAL	20260201	N/A	ANDA	ANDA217231	Dr. Reddy’s Laboratories Inc.	TOPIRAMATE	50 mg/1	30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (43598-940-30)
43598-941-01	43598-941	HUMAN PRESCRIPTION DRUG	Topiramate	Topiramate	CAPSULE, EXTENDED RELEASE	ORAL	20260201	N/A	ANDA	ANDA217231	Dr. Reddy’s Laboratories Inc.	TOPIRAMATE	100 mg/1	100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (43598-941-01)
43598-941-30	43598-941	HUMAN PRESCRIPTION DRUG	Topiramate	Topiramate	CAPSULE, EXTENDED RELEASE	ORAL	20260201	N/A	ANDA	ANDA217231	Dr. Reddy’s Laboratories Inc.	TOPIRAMATE	100 mg/1	30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (43598-941-30)
43598-942-01	43598-942	HUMAN PRESCRIPTION DRUG	Topiramate	Topiramate	CAPSULE, EXTENDED RELEASE	ORAL	20260201	N/A	ANDA	ANDA217231	Dr. Reddy’s Laboratories Inc.	TOPIRAMATE	200 mg/1	100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (43598-942-01)
43598-942-30	43598-942	HUMAN PRESCRIPTION DRUG	Topiramate	Topiramate	CAPSULE, EXTENDED RELEASE	ORAL	20260201	N/A	ANDA	ANDA217231	Dr. Reddy’s Laboratories Inc.	TOPIRAMATE	200 mg/1	30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (43598-942-30)